Buy me a coffee
Home › FDA recalls › Buprenorphine Sublingual Tablets
CLASS III · LowFDA

American Health Packaging recalls Buprenorphine Sublingual Tablets

📅 Aug 19, 2026 · 📍 Nationwide
Recalling company
American Health Packaging
Product
Buprenorphine Sublingual Tablets (C-III), 2 mg, 30 Tablets (3x10), Rx only, Distributed by: American Health Packaging, Columbus, Ohio 43217, Carton NDC#: 60687-481-21, (Individual Dose NDC: 60687-481-11).
Reason
Labeling: Label Mix-up
Classification
Class III – not likely to cause adverse health consequences
Recall date
Aug 19, 2026
Reported
Sep 9, 2026
Distribution
US Nationwide.
Status
Ongoing
Quantity
10,953 cartons.
Lot / codes
Lot # 1030023, Exp Date: 06/30/2027.
Company location
Columbus, OH
Recall type
Voluntary: Firm initiated
Recall number
D-0840-2026
Agency
U.S. Food and Drug Administration (FDA)

View official FDA notice ↗ Search recall number D-0840-2026 in the FDA Enforcement Report. Also see FDA recall press releases.

If you use this product, check the lot, NDC or model number against the official notice and follow its instructions. Do not stop a prescribed medicine or remove a medical device without talking to your doctor or pharmacist. Report problems to FDA MedWatch. FoodRecallNow summarizes public FDA data and is not medical advice.